1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2015 World HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for

Complete report $4,850. DataPack (test volumes, sales forecasts, supplier shares) $3,100.




Summary



This 7-country report presents detailed analyses of the AIDS diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  For each country, the report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/ NAT, Western Blot,
HTLV-I/II and other confirmatory tests performed in the following market segments:


    - Hospitals

    - Commercial/Private Laboratories

    - Blood Banks

    - Physician Offices

    - Public Health Laboratories


For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.


Highlights



  • Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.

  • Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.

  • Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter, bioMerieux, Ortho Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.

  • Profiles over 30 leading manufacturers and potential market entrants developing innovative technologies and products.

  • Analyzes alternative market penetration strategies for suppliers.


Methodology

The report is based on a combination of primary and secondary information
sources, including VPGMarketResearch’s proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments.  The database contains information on companies, technologies, products and executives worldwide.  Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.


The report is based on a combination of primary and secondary information
sources, including VPGMarketResearch’s proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments.  The database contains information on companies, technologies, products and executives worldwide.  Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

Contains 288 pages and 43 tables


 


This 7-country report presents detailed analyses of the AIDS diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. For each country, the report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:

Table Of Contents

2015 World HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for
TABLE OF CONTENTS
I. Introduction
II. AIDS/HIV Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests: HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. France: Market Size, Growth and Major Suppliers'
Sales and Market Shares
IV. Germany: Market Size, Growth and Major Suppliers'
Sales and Market Shares
V. Italy: Market Size, Growth and Major Suppliers'
Sales and Market Shares
VI. Japan: Market Size, Growth and Major Suppliers'
Sales and Market Shares
VII. Spain: Market Size, Growth and Major Suppliers'
Sales and Market Shares
VIII. UK: Market Size, Growth and Major Suppliers'
Sales and Market Shares
IX. USA: Market Size, Growth and Major Suppliers'
Sales and Market Shares
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. Potential Market Entry Barriers and Risks

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. Competitive Assessments

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests

France: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

France: HIV Ag Test Volume and Sales Forecasts
By Market Segment
France: HIV NAT Blood Screening Test Volume and Diagnostics Sales

France: Western Blot/Other Confirmatory Tests Volume
and Sales Forecasts by Market Segment

France: AIDS Diagnostics Market by Major Supplier
France: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

Germany: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

Germany: HIV Ag Test Volume and Sales Forecasts
By Market Segment
Germany: HIV NAT Blood Screening Test Volume and Diagnostics Sales

Germany: Western Blot/Other Confirmatory Tests Volume
and Sales Forecasts by Market Segment

Germany: AIDS Diagnostics Market by Major Supplier
Germany: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

Italy: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

Italy: HIV Ag Test Volume and Sales Forecasts
By Market Segment
Italy: HIV NAT Blood Screening Test Volume and Diagnostics Sales

Italy: Western Blot/Other Confirmatory Tests Volume
and Sales Forecasts by Market Segment

Italy: AIDS Diagnostics Market by Major Supplier
Italy: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

Japan: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

Japan HIV Ag Test Volume and Sales Forecasts
By Market Segment
Japan: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Japan: Western Blot/Other Confirmatory Tests Volume
and Sales Forecasts by Market Segment

Japan: AIDS Diagnostics Market by Major Supplier
Japan: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

Spain: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

Spain: HIV Ag Test Volume and Sales Forecasts
By Market Segment
Spain: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Spain: Western Blot/Other Confirmatory Tests Volume
and Sales Forecasts by Market Segment

Spain: AIDS Diagnostics Market by Major Supplier
Spain: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

UK: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

UK: HIV Ag Test Volume and Sales Forecasts
By Market Segment
UK: HIV NAT Blood Screening Test Volume and Diagnostics Sales
UK: Western Blot/Other Confirmatory Tests Volume
and Sales Forecasts by Market Segment

UK: AIDS Diagnostics Market by Major Supplier
UK: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

USA: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

USA: HIV Ag Test Volume and Sales Forecasts
By Market Segment
USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales

USA: Western Blot/Other Confirmatory Tests Volume
and Sales Forecasts by Market Segment

USA: AIDS Diagnostics Market by Major Supplier
USA: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

Contains 288 pages and 43 tables

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review,  Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.